SVRA
Savara Inc
NASDAQ · Healthcare · Biotechnology · US
$4.63
+4.04%Leverage
- Debt / equity
- 0.21x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -0.22x
- Net debt / EBITDA
- 0.08x
Liquidity & coverage
- Current ratio
- 10.13x
- Quick ratio
- 10.13x
- Cash ratio
- 9.83x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $160.7M
Cash & dividend
- FCF / debt
- -3.68x
- Cash flow / debt
- -3.67x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026